Re-Read the update, it is a clinical, but already has guaranteed funding from sources. I have know idea what the product is. I told the board months ago when Keywood came on board she was bring an experimental drug and AMBS would be buying. (It was just a guess on my part.)
I would not be surprised if it is a vaccine that Wakefield is toting.